Dr. Parameswaran Hari, MD
Claim this profileMedical College of Wisconsin
Studies Multiple Myeloma
Studies Plasma Cell Neoplasm
6 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Parameswaran Hari, MD is currently running
Gene Therapy
for Hemophilia A
This is a Phase I study. This research study is being conducted to find new ways to treat severe hemophilia A. This study is a gene therapy study. Gene therapy is an experimental way to introduce, into a person's cells, specific genetic material. A gene can be delivered/introduced into a cell using a carrier known as a "vector." In this study, a virus (lentivirus), the "vector", is used to introduce or deliver a gene that creates and stores a protein Factor VIII (FVIII) in your platelets. These platelets are made from stem cells (mother cells for your bone marrow) that are removed from your blood by a procedure called apheresis. This research study will take some of the patient's own stem cells, from the apheresis procedure, and genetically modify them using the vector in order to make them produce FVIII in platelets that arise from the stem cells. They will then give the genetically modified stem cells back to the patient so that they can possibly create platelets that produce and store Factor VIII on their own.
Recruiting2 awards Phase 110 criteria
Lenalidomide +/- Daratumumab
for Multiple Myeloma
Patients are enrolled to screening (Reg Step 1) prior to or after ASCT but prior to Reg Step 2. Patients are followed until they will begin Maintenance and then registered to Reg Step 2 (first randomization). Patients are randomized between Lenalidomide for 2 years and Lenalidomide + Daratumumab/rHuPH20. After 2 years of Maintenance, MRD is assessed to guide further therapy. MRD-positive patients will continue with the assigned treatment. MRD-negative patients will be further randomized (Reg Step 3) to either continue or discontinue the assigned treatment. Patients are treated for up to 7 years from Step 2 reg and followed for up to 15 years.
Recruiting2 awards Phase 317 criteria
More about Parameswaran Hari, MD
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Parameswaran Hari, MD has experience with
- Daratumumab/rHuPH20
- Lenalidomide
- WHG626
- WVT078
- MMprofiler
- ALLO-715
Breakdown of trials Parameswaran Hari, MD has run
Multiple Myeloma
Plasma Cell Neoplasm
T-Lymphoblastic Leukemia/Lymphoma
Uterine Tumors
Acute Lymphoblastic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Parameswaran Hari, MD specialize in?
Parameswaran Hari, MD focuses on Multiple Myeloma and Plasma Cell Neoplasm. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Parameswaran Hari, MD currently recruiting for clinical trials?
Yes, Parameswaran Hari, MD is currently recruiting for 2 clinical trials in Milwaukee Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Parameswaran Hari, MD has studied deeply?
Yes, Parameswaran Hari, MD has studied treatments such as Daratumumab/rHuPH20, Lenalidomide, WHG626.
What is the best way to schedule an appointment with Parameswaran Hari, MD?
Apply for one of the trials that Parameswaran Hari, MD is conducting.
What is the office address of Parameswaran Hari, MD?
The office of Parameswaran Hari, MD is located at: Medical College of Wisconsin, Milwaukee, Wisconsin 53226 United States. This is the address for their practice at the Medical College of Wisconsin.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.